drugset / Trial / NCT01766843

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

NCT01766843

Phase 1 Completed 50 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverQuadruple-blind

Summary

The purpose of this study is to compare the test product Salmeterol/fluticasone Easyhaler with the reference product Seretide Diskus in terms of drug absorbed in the bloodstream.

Timeline

Start
2013-01
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol/Fluticasone Propionate Unknown 50 ug Inhaled
Subject Salmeterol/Fluticasone Propionate Unknown 50 ug Inhaled
Comparator Salmeterol/Fluticasone Propionate Unknown 500 ug Inhaled
Subject Salmeterol/Fluticasone Propionate Unknown 500 ug Inhaled
Comparator charcoal Unknown

Indications